| Otolaryngology |
1 |
1 |
| Food Allergy |
0 |
0.48 |
| Diet |
0 |
0.45 |
| Esophagus |
0 |
0.45 |
| Allergy |
0 |
0.39 |
| Child |
0 |
0.39 |
| Achalasia |
0 |
0.38 |
| Eosinophilic Esophagitis |
0 |
0.99 |
| Biologic Therapy |
0 |
0.34 |
| Esophageal Stricture |
0 |
0.32 |
| Esophagitis |
0 |
0.26 |
| Gastroesophageal Reflux Disease |
0 |
0.23 |
| Eosinophils |
0 |
0.19 |
| Remission |
0 |
0.19 |
| Genomic Medicine |
0 |
0.17 |
| Neonatal Intensive Care Unit (NICU) |
0 |
0.15 |
| Helicobacter Pylori |
0 |
0.14 |
| Biopsy |
0 |
0.13 |
| Dysphagia |
0 |
0.13 |
| Europe |
0 |
0.13 |
| Genetics |
0 |
0.13 |
| Monoclonal Antibody |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| Clinical Guidelines |
0 |
0.11 |
| Intensive Care Unit |
0 |
0.11 |
| Antibiotics |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Microbiome |
0 |
0.09 |
| Pregnancy |
0 |
0.09 |
| Serum Immunoglobulin A (IgA) |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Adherence |
0 |
0.06 |
| Allergens |
0 |
0.06 |
| Artificial Intelligence |
0 |
0.06 |
| Cesarean Delivery |
0 |
0.06 |
| Edema |
0 |
0.06 |
| Failure to Thrive |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Glucocorticoid |
0 |
0.06 |
| Heartburn |
0 |
0.06 |
| Immunoglobulin A (IgA) |
0 |
0.06 |
| Interleukin |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Nasopharyngitis |
0 |
0.06 |
| New York |
0 |
0.06 |
| Proton Pump Inhibitor |
0 |
0.06 |
| Quality of Life |
0 |
0.06 |
| Rare Diseases |
0 |
0.06 |
| Rural Health |
0 |
0.06 |
| Stenosis |
0 |
0.06 |
| Steroids |
0 |
0.06 |
| UK Site Content |
0 |
0.06 |